Literature DB >> 6706403

Isolation of a Streptococcus mutans strain producing a novel bacteriocin.

J D Hillman, K P Johnson, B I Yaphe.   

Abstract

A strain of Streptococcus mutans has been isolated that produces a bacteriocin with novel properties. Its antibiotic spectrum includes 123 of 124 strains of S. mutans tested and a variety of other gram-positive microorganisms. Experiments with dialysis membranes indicate that the molecular weight of the bacteriocin is less than 1,000. Mutants of the producer strain were obtained that are deficient in bacteriocin production or produce twofold elevated amounts. The ability of these strains to superinfect or preemptively colonize the oral cavities of rats correlated with the amount of bacteriocin they produced.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6706403      PMCID: PMC263483          DOI: 10.1128/iai.44.1.141-144.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  A new family of low molecular weight antibiotics from enterobacteria.

Authors:  C Asensio; J C Pérez-Díaz
Journal:  Biochem Biophys Res Commun       Date:  1976-03-08       Impact factor: 3.575

2.  Bacteriocinogeny and the properties of some bacteriocins of Streptococcus mutans.

Authors:  A H Rogers
Journal:  Arch Oral Biol       Date:  1976       Impact factor: 2.633

3.  Bacteriocin types of Streptococcus mutans in human mouths.

Authors:  A H Rogers
Journal:  Arch Oral Biol       Date:  1975-12       Impact factor: 2.633

4.  Bacteriocin patterns of strains belonging to various serotypes of Streptococcus mutans.

Authors:  A H Rogers
Journal:  Arch Oral Biol       Date:  1976       Impact factor: 2.633

5.  The early establishment of Streptococcus mutans in the mouths of infants.

Authors:  R J Berkowitz; H V Jordan; G White
Journal:  Arch Oral Biol       Date:  1975-03       Impact factor: 2.633

6.  Production and properties of bacteriocins (mutacins) from Streptococcus mutans.

Authors:  S Hamada; T Ooshima
Journal:  Arch Oral Biol       Date:  1975-10       Impact factor: 2.633

7.  A selective medium for Streptococcus mutans.

Authors:  O G Gold; H V Jordan; J Van Houte
Journal:  Arch Oral Biol       Date:  1973-11       Impact factor: 2.633

8.  Bacteriocins from human and rodent streptococci.

Authors:  J Kelstrup; R J Gibbons
Journal:  Arch Oral Biol       Date:  1969-03       Impact factor: 2.633

9.  Fingerprinting human oral streptococci by bacteriocin production and sensitivity.

Authors:  J Kelstrup; S Richmond; C West; R J Gibbons
Journal:  Arch Oral Biol       Date:  1970-12       Impact factor: 2.633

10.  Production and properties of an extracellular bacteriocin from Streptococcus mutans bacteriocidal for group A and other streptococci.

Authors:  D Paul; H D Slade
Journal:  Infect Immun       Date:  1975-12       Impact factor: 3.441

View more
  28 in total

1.  Construction and characterization of an effector strain of Streptococcus mutans for replacement therapy of dental caries.

Authors:  J D Hillman; T A Brooks; S M Michalek; C C Harmon; J L Snoep; C C van Der Weijden
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Production of bacteriolytic activity in the oral cavity by nutritionally variant streptococci.

Authors:  R Pompei; E Caredda; V Piras; C Serra; L Pintus
Journal:  J Clin Microbiol       Date:  1990-07       Impact factor: 5.948

3.  Genetic and physiologic analysis of a formyl-tetrahydrofolate synthetase mutant of Streptococcus mutans.

Authors:  P J Crowley; J A Gutierrez; J D Hillman; A S Bleiweis
Journal:  J Bacteriol       Date:  1997-03       Impact factor: 3.490

4.  Pharmacological, Toxicological, and Dose Range Assessment of OG716, a Novel Lantibiotic for the Treatment of Clostridium difficile-Associated Infection.

Authors:  Mark E Pulse; William J Weiss; Johan A Kers; Anthony W DeFusco; Jae H Park; Martin Handfield
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

5.  Genetic and biochemical analysis of mutacin 1140, a lantibiotic from Streptococcus mutans.

Authors:  J D Hillman; J Novák; E Sagura; J A Gutierrez; T A Brooks; P J Crowley; M Hess; A Azizi; K Leung; D Cvitkovitch; A S Bleiweis
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

Review 6.  Ecological Therapeutic Opportunities for Oral Diseases.

Authors:  Anilei Hoare; Philip D Marsh; Patricia I Diaz
Journal:  Microbiol Spectr       Date:  2017-08

7.  Evaluation of the effects of Streptococcus mutans chaperones and protein secretion machinery components on cell surface protein biogenesis, competence, and mutacin production.

Authors:  P J Crowley; L J Brady
Journal:  Mol Oral Microbiol       Date:  2015-10-07       Impact factor: 3.563

8.  DNA sequence and in vitro mutagenesis of the gene encoding the fructose-1,6-diphosphate-dependent L-(+)-lactate dehydrogenase of Streptococcus mutans.

Authors:  M J Duncan; J D Hillman
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

9.  Site-directed mutations in the lanthipeptide mutacin 1140.

Authors:  Shaorong Chen; Shawanda Wilson-Stanford; William Cromwell; Jeffrey D Hillman; Adam Guerrero; Charlotte A Allen; Joseph A Sorg; Leif Smith
Journal:  Appl Environ Microbiol       Date:  2013-04-19       Impact factor: 4.792

10.  Purification and biochemical properties of a bacteriocin from Actinobacillus actinomycetemcomitans.

Authors:  R H Stevens; S E Lillard; B F Hammond
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.